ReviewFrontiers in physiology2026
Methods to localize cell specific alterations within the 3D context of the lung.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The lung is a heterogeneous organ, composed of morphologically different sub-compartments. When analyzing lung pathologies, it is important to collect the spatial location of lesions, to allow the translation of e.g. preclinical study results to the human lung, or the formulation of targeted treatment strategies. For the purpose of this review, bronchopulmonary dysplasia will serve as an example for a lung pathology to be studied, but the methods demonstrated can be adapted to other pathologies as well. The review's focus will lie on common histological methods and the potential to use them for both the study of cellular features and location assessment. Morphological characteristics, as well as intracellular states related to cell cycle and cell death will be considered. In an advanced section, the combination of multiple imaging methods into analysis pipelines is detailed, describing different combinatorial possibilities with their advantages and use in the research context. Through the integration of microscopy and computed tomography into one process, it is possible to assess both 3D location and cellular features, with the option of employing immunohistochemical markers for the detection of specific proteins as well. This is a tool that can be used in addressing both transitional and longitudinal research questions regarding lung pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.